Recent 8-K filings for AURX

• May 14, 2026, 5:11 PM ET earnings materiality 0.60 positive item 2.02item 9.01

  Nuo Therapeutics Q1 revenues up 169% YoY to $1.3M; operating loss narrows

  Total revenue $1.3M, including $1.22M product sales, up 169% YoY and 20% sequential.

• January 26, 2026, 6:59 PM ET debt materiality 0.65 neutral item 1.01item 2.03item 3.02item 9.01 ◈ Debt Financings◈ Material Agreements

  Nuo Therapeutics secures up to $1.6M loan with 10%-12% PIK interest paid in warrants; insider participation

  Loan agreement for $1.0M initial + $600K second tranche (Sept 30, 2026); $1.0M funded Jan 23, 2026.

• December 17, 2025, 6:59 PM ET other materiality 0.10 neutral item 5.07

  Nuo Therapeutics shareholders elect four directors and ratify auditor at 2025 annual meeting

  All four director nominees elected: David E. Jorden, Paul D. Mintz, Scott M. Pittman, C. Eric Winzer.

• October 10, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.02item 5.08item 8.01

  Nuo Therapeutics raises CEO and COO salaries, sets Dec 16 annual meeting

  CEO David E. Jorden salary increased to $325,000 effective Oct 1, 2025.

• May 15, 2025, 7:59 PM ET other material materiality 0.35 neutral item 1.01

  Nuo Therapeutics enters interim sales agency agreement with Smith+Nephew for Aurix products

  Amendment to Distribution Agreement grants Smith+Nephew interim sales agent role for Nuo Aurix brand to certain Smith+Nephew customers.

• September 19, 2024, 7:59 PM ET other material materiality 0.40 neutral item 1.01item 3.02item 9.01

  Nuo Therapeutics raises $849k in private placement of 1.13M shares at $0.75/share

  Gross proceeds of $849,125 from sale of 1,132,167 shares at $0.75 per share.

• June 27, 2024, 7:59 PM ET other material materiality 0.50 neutral item 8.01

  Pacific Medical exercises full warrant for 356,889 shares of Nuo Therapeutics common stock

  Pacific Medical exercised warrant for 270,000 shares at $0.56/share, raising $151,200 in cash proceeds.

• June 11, 2024, 7:59 PM ET other material materiality 0.65 negative item 4.01item 9.01

  Nuo Therapeutics dismisses auditor Marcum, engages MaloneBailey; cites material weaknesses

  Effective June 7, 2024, dismissed Marcum LLP as independent auditor; engaged MaloneBailey, LLP for FY 2024.

• May 21, 2024, 7:59 PM ET other material materiality 0.40 neutral item 1.01item 3.02item 9.01

  Nuo Therapeutics raises $650,875 in private placement of 867,833 shares at $0.75/share

  Gross proceeds of $650,875 from sale of 867,833 shares of common stock at $0.75 per share.

Materiality & sentiment trend

Max materiality 0.65 · Median 0.40 · Most common event other_material

1 positive 1 negative 7 neutral

source · AURX on sec.gov